GRCE (STOCKS)
Grace Therapeutics, Inc. Common Stock
$2.074000
-0.026000 (-1.24%)
Prev close: $2.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Prashant Kohli
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $34.01M
- Employees
- 6
- P/E (TTM)
- -4.31
- P/B (TTM)
- 0.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q4)
|
$-0.06 | $-0.23 | +0.1746 | +74.42% |
|
Dec 2025 (Q3)
|
$-0.14 | $-0.29 | +0.1456 | +50.98% |
|
Sep 2025 (Q2)
|
$-0.06 | $-0.19 | +0.1287 | +68.20% |
|
Jun 2025 (Q1)
|
$-0.21 | $-0.22 | +0.0144 | +6.42% |
Financial Statements
| Nonoperating Income/Loss | $1.58M |
| Research and Development | $2.41M |
| Operating Income/Loss | -$11.08M |
| Income/Loss From Continuing Operations After Tax | -$7.79M |
| Income/Loss From Continuing Operations Before Tax | -$9.49M |
| Income Tax Expense/Benefit | -$1.70M |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | -$1.70M |
| Net Income/Loss | -$7.79M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.79M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.79M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.47 |
| Diluted Earnings Per Share | -$0.47 |
| Basic Average Shares | 16,510,632 |
| Diluted Average Shares | 16,510,632 |
| Assets | $66.65M |
| Current Assets | $17.38M |
| Prepaid Expenses | $383.00K |
| Other Current Assets | $17.00M |
| Noncurrent Assets | $49.27M |
| Fixed Assets | $8.00K |
| Intangible Assets | $41.13M |
| Other Non-current Assets | $8.14M |
| Liabilities | $2.76M |
| Current Liabilities | $2.15M |
| Wages | $719.00K |
| Other Current Liabilities | $1.43M |
| Noncurrent Liabilities | $612.00K |
| Equity | $63.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $63.90M |
| Liabilities And Equity | $66.65M |
| Net Cash Flow From Operating Activities | -$8.87M |
| Net Cash Flow From Operating Activities, Continuing | -$8.87M |
| Net Cash Flow From Investing Activities | $5.16M |
| Net Cash Flow From Investing Activities, Continuing | $5.16M |
| Net Cash Flow From Financing Activities | $3.71M |
| Net Cash Flow From Financing Activities, Continuing | $3.71M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$7.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.79M |
| Other Comprehensive Income/Loss | -$7.79M |